Finerenone ameliorates diabetic cardiomyopathy by modulating inflammation through the FoxO3a/Acod1/MAPK axis

Journal of Diabetes and its Complications · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles